Drug Profile
Oxybutynin - Labopharm
Alternative Names: Oxybutynin once-daily - LabopharmLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Labopharm
- Class Alkynes; Antispasmodics; Carbocyclic acids; Cyclohexanes; Diethylamines; Esters; Mandelic acids; Skin disorder therapies; Small molecules
- Mechanism of Action Cholinergic receptor antagonists; Muscarinic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Overactive bladder
Most Recent Events
- 20 May 2004 Phase-I clinical trials in Overactive bladder in Canada (unspecified route)
- 20 May 2003 Preclinical trials in Overactive bladder in Canada (unspecified route)